ONXX Higher on Earnings Thursday, November 4, 11:03 AM ET, by Market News Video Staff Onyx Pharmaceuticals shares are trading higher today after the company posted a jump in third ...
REGN Announces Positive Trial Results Monday, November 22, 1:34 PM ET, by Market News Video Staff Regeneron Pharmaceuticals (REGN) shares are trading higher today after it and Bayer HealthCare announced positive ...
SPDR S&P Biotech ETF Experiences Big Outflow Tuesday, May 31, 1:32 PM ET, by Market News Video Staff Symbols mentioned in this story: XBI, CBST, ACOR Exchange traded funds (ETFs) trade just like ...
SPDR S&P Biotech ETF Experiences Big Inflow Monday, June 13, 10:50 AM ET, by Market News Video Staff Symbols mentioned in this story: XBI, VRUS, CBST Exchange traded funds (ETFs) trade just like ...
In trading on Friday, shares of Momenta Pharmaceuticals Inc (NASDAQ:MNTA) crossed above their 200 day moving average of $16.75, changing hands as high as $16.81 per share. Momenta Pharmaceuticals Inc shares are currently trading up about 2.2% on the day. The chart below shows the one year performance of MNTA shares, versus its 200 day moving average:
Looking at the chart above, MNTA's low point in its 52 week range is $10.15 per share, with $21.00 as the 52 week high point — that compares with a last trade of $16.55.
According to the ETF Finder at ETF Channel, MNTA makes up 2.96% of the SPDR S&P Biotech ETF (AMEX:XBI) which is trading higher by about 1.1% on the day Friday.
This Article's Word Cloud:AMEXAboveAccordingAverageBiotechDaysETFsFridayJoinLookingMNTAMomentaMovingOfferPharmaceuticalsSevenSpecialStartStocksTheiraboutaboveaveragebelowchangingchartcontainconversationcrossedcurrentlyhandshighhigherincomeinvitationmovingotherperformancepointrangeraquosharesharesspecialstockstradetradingweekwhatwith
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.